Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000393692 | SCV000338973 | uncertain significance | not provided | 2016-02-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765637 | SCV000896966 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 28 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000393692 | SCV001823206 | likely benign | not provided | 2019-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000393692 | SCV002184449 | uncertain significance | not provided | 2022-06-09 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 428 of the TRIOBP protein (p.Pro428Arg). This variant is present in population databases (rs372134073, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with TRIOBP-related conditions. ClinVar contains an entry for this variant (Variation ID: 285798). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |